[go: up one dir, main page]

WO2008010070A3 - Nouveaux dérivés d'oxazolidinone - Google Patents

Nouveaux dérivés d'oxazolidinone Download PDF

Info

Publication number
WO2008010070A3
WO2008010070A3 PCT/IB2007/002019 IB2007002019W WO2008010070A3 WO 2008010070 A3 WO2008010070 A3 WO 2008010070A3 IB 2007002019 W IB2007002019 W IB 2007002019W WO 2008010070 A3 WO2008010070 A3 WO 2008010070A3
Authority
WO
WIPO (PCT)
Prior art keywords
present
pneumoniae
derivatives
oxazolidinone derivatives
novel oxazolidinone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2007/002019
Other languages
English (en)
Other versions
WO2008010070A2 (fr
Inventor
Uma Ramachandran
Mrinal Kanti Guha
Ravikumar Tadiparthi
Ganesh Prabhu
Vijayalakshmi Vadarevu
Simi Pushpan
Veenaa Anantharaman
Santhosh Subramanian
Shakti Singh Solanki
Matte Marianna Samuel
Kesavan Koppolu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Orchid Research Laboratories Ltd
Original Assignee
Orchid Research Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orchid Research Laboratories Ltd filed Critical Orchid Research Laboratories Ltd
Publication of WO2008010070A2 publication Critical patent/WO2008010070A2/fr
Anticipated expiration legal-status Critical
Publication of WO2008010070A3 publication Critical patent/WO2008010070A3/fr
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne de nouveaux composés de formule générale (I) et les dérivés, analogues, formes tautomères, stéréoisomères, polymorphes, hydrates, solvates, sels acceptables du point de vue pharmaceutique, compositions pharmaceutiques, métabolites et promédicaments de ceux-ci. La présente invention concerne plus particulièrement de nouveaux dérivés d'oxazolidinone de formule générale (I). Les nouveaux dérivés d'oxazolidinone de la présente invention peuvent être utiles en tant qu'agents antibactériens, en particulier pour des injections intraveineuses, et ils sont également utiles dans le traitement d'affections telles que les pneumonies nosocomiales, les pneumonies extrahospitalières, les entérocoques résistants à la vancomycine (ERV) provoqués par le staphylocoque doré (Staphylococcus aureus) résistant à la méthicilline (SARM) et les pneumonies à streptocoque résistant à la pénicilline. Les composés de la présente invention sont efficaces contre un certain nombre d'isolats cliniques pathogènes humains ou animaux, dont des organismes résistants à la vancomycine et à la méthicilline.
PCT/IB2007/002019 2006-07-19 2007-07-18 Nouveaux dérivés d'oxazolidinone Ceased WO2008010070A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1253CH2006 2006-07-19
IN1253/CHE/2006 2006-07-19

Publications (2)

Publication Number Publication Date
WO2008010070A2 WO2008010070A2 (fr) 2008-01-24
WO2008010070A3 true WO2008010070A3 (fr) 2010-02-11

Family

ID=38957145

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2007/002019 Ceased WO2008010070A2 (fr) 2006-07-19 2007-07-18 Nouveaux dérivés d'oxazolidinone

Country Status (1)

Country Link
WO (1) WO2008010070A2 (fr)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993023384A1 (fr) * 1992-05-08 1993-11-25 The Upjohn Company Oxazolidinones contenant une fraction diazine substituee et leur utilisation comme antimicrobiens
JPH11322729A (ja) * 1998-03-09 1999-11-24 Hokuriku Seiyaku Co Ltd ジチオカルバミド酸誘導体
EP1130016A1 (fr) * 1998-11-11 2001-09-05 Hokuriku Seiyaku Co., Ltd. Derives d'acide thiocarbamique

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993023384A1 (fr) * 1992-05-08 1993-11-25 The Upjohn Company Oxazolidinones contenant une fraction diazine substituee et leur utilisation comme antimicrobiens
JPH11322729A (ja) * 1998-03-09 1999-11-24 Hokuriku Seiyaku Co Ltd ジチオカルバミド酸誘導体
EP1130016A1 (fr) * 1998-11-11 2001-09-05 Hokuriku Seiyaku Co., Ltd. Derives d'acide thiocarbamique

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE CAPLUS [online] 20 March 2009 (2009-03-20), Database accession no. 2007:249549 *
DATABASE CAPLUS [online] 20 March 2009 (2009-03-20), Database accession no. 2007:413000 *

Also Published As

Publication number Publication date
WO2008010070A2 (fr) 2008-01-24

Similar Documents

Publication Publication Date Title
WO2008154642A3 (fr) Agents antibactériens
DE60331056D1 (de) 6-11 bicyclische ketolidderivate
WO2010115184A3 (fr) Hydroxylthiénoquinolones et composés apparentés utilisables en tant qu'agents anti-infectieux
CY1121284T1 (el) Θεραπεια ασθενειων που συνδυαζονται με τη χρηση αντιβιοτικων
WO2010047737A3 (fr) Composés indoliniques antimicrobiens pour le traitement d'infections bactériennes
EP3216798A3 (fr) Composés kétolides
TN2010000038A1 (en) Organic compounds
IL185164A0 (en) New isothiazoloquinolones and related compounds as anti-infective agents
NO20091254L (no) Terapeutiske sammensetninger
MY156304A (en) 5-hydroxymethyl-oxazolidin-2-one derivatives for treating bacterial intestinal diseases
MX2010002932A (es) Macrolidos de biarilo con puente en 6, 11.
WO2009001192A3 (fr) Nouveaux composés et leur utilisation
WO2009116044A3 (fr) Composés pour le traitement d’infections bactériennes
WO2007138112A3 (fr) Composés interagissant avec des canaux ioniques, notamment des canaux ioniques de la famille kv
WO2005070945A8 (fr) Nouvel aminoside efficace contre le staphylococcus aureus resistant a la methicilline (mrsa)
WO2008038092A3 (fr) Pipéridinophényloxazolidinones substituées
WO2019199496A1 (fr) Agents antibactériens à base de benzamide
WO2005070113A3 (fr) Derives d'erythromycine bicycliques 9-n substitues en c6-c11
TW200634021A (en) 3,6-bicyclolides
MX2013011272A (es) Derivado de oxazolidinona novedoso y composicion farmaceutica que incluye el mismo.
WO2010058423A3 (fr) Nouveaux agents antimicrobiens
WO2010036000A3 (fr) Nouveaux dérivés d'oxazolidinone avec une amidoxime cyclique ou une amidrazone cyclique et compositions pharmaceutiques les comprenant
WO2008152068A3 (fr) Dérivés de [1,10]-phénanthroline pour le traitement de maladies neurodégénératives ou hématologiques
WO2008010070A3 (fr) Nouveaux dérivés d'oxazolidinone
WO2006065721A3 (fr) Bicyclolides de 11, 12-lactone

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07804619

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

122 Ep: pct application non-entry in european phase

Ref document number: 07804619

Country of ref document: EP

Kind code of ref document: A2